InProTher is an immunotherapy company dedicated to developing the world’s first adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses that normally are dormant in the human genome.  The retroviral genes are reactivated in cancer and essential for tumor development.  InProTher’s proprietary combination of novel technologies is designed to break tolerance to this unique antigen family, thus providing broad anti-cancer efficacy.

Contact name:

Valdemar Stage


Ole Maaløes Vej 3, 2200 København



Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

Copyright 2021 Danskbiotek. All rights reserved.